Dokument-ID Dokumenttyp Verfasser/Autoren Herausgeber Haupttitel Abstract Auflage Verlagsort Verlag Erscheinungsjahr Seitenzahl Schriftenreihe Titel Schriftenreihe Bandzahl ISBN Quelle der Hochschulschrift Konferenzname Quelle:Titel Quelle:Jahrgang Quelle:Heftnummer Quelle:Erste Seite Quelle:Letzte Seite URN DOI Abteilungen OPUS4-16181 Dissertation Simon, Katja Identifying the role of Myb-MuvB in gene expression and proliferation of lung cancer cells The evolutionary conserved Myb-MuvB (MMB) multiprotein complex is a transcriptional master regulator of mitotic gene expression. The MMB subunits B-MYB, FOXM1 as well as target genes of MMB are often overexpressed in different cancer types. Elevated expression of these genes correlates with an advanced tumor state and a poor prognosis for patients. Furthermore, it has been reported that pathways, which are involved in regulating the mitotic machinery are attractive for a potential treatment of cancers harbouring Ras mutations (Luo et al., 2009). This suggest that the MMB complex could be required for tumorigenesis by mediating overactivity of mitotic genes and that the MMB could be a useful target for lung cancer treatment. However, although MMB has been characterized biochemically, the contribution of MMB to tumorigenesis is largely unknown in particular in vivo. In this thesis, it was demonstrated that the MMB complex is required for lung tumorigenesis in vivo in a mouse model of non small cell lung cancer. Elevated levels of B-MYB, NUSAP1 or CENPF in advanced tumors as opposed to low levels of these proteins levels in grade 1 or 2 tumors support the possible contribution of MMB to lung tumorigenesis and the oncogenic potential of B-MYB.The tumor growth promoting function of B-MYB was illustrated by a lower fraction of KI-67 positive cells in vivo and a significantly high impairment in proliferation after loss of B-Myb in vitro. Defects in cytokinesis and an abnormal cell cycle profile after loss of B-Myb underscore the impact of B-MYB on proliferation of lung cancer cell lines. The incomplete recombination of B-Myb in murine lung tumors and in the tumor derived primary cell lines illustrates the selection pressure against the complete loss of B-Myb and further demonstrats that B-Myb is a tumor-essential gene. In the last part of this thesis, the contribution of MMB to the proliferation of human lung cancer cells was demonstrated by the RNAi-mediated depletion of B-Myb. Detection of elevated B-MYB levels in human adenocarcinoma and a reduced proliferation, cytokinesis defects and abnormal cell cycle profile after loss of B-MYB in human lung cancer cell lines underlines the potential of B-MYB to serve as a clinical marker. 2019 urn:nbn:de:bvb:20-opus-161814 10.25972/OPUS-16181 Graduate School of Life Sciences OPUS4-15410 Dissertation Iltzsche, Fabian The Role of DREAM/MMB-mediated mitotic gene expression downstream of mutated K-Ras in lung cancer The evolutionary conserved Myb-MuvB (MMB) multiprotein complex has an essential role in transcriptional activation of mitotic genes. MMB target genes as well as the MMB associated transcription factor B-Myb and FoxM1 are highly expressed in a range of different cancer types. The elevated expression of these genes correlates with an advanced tumor state and a poor prognosis. This suggests that MMB could contribute to tumorigenesis by mediating overexpression of mitotic genes. Although MMB has been extensively characterized biochemically, the requirement for MMB to tumorigenesis in vivo remains largely unknown and has not been tested directly so far. In this study, conditional knockout of the MMB core member Lin9 inhibits tumor formation in vivo in a mouse model of lung cancer driven by oncogenic K-Ras and loss of p53. The incomplete recombination observed within tumors points towards an enormous selection pressure against the complete loss of Lin9. RNA interference (RNAi)-mediated depletion of Lin9 or the MMB associated subunit B-Myb provides evidence that MMB is required for the expression of mitotic genes in lung cancer cells. Moreover, it was demonstrated that proliferation of lung cancer cells strongly depends on MMB. Furthermore, in this study, the relationship of MMB to the p53 tumor suppressor was investigated in a primary lung cancer cell line with restorable p53 function. Expression analysis revealed that mitotic genes are downregulated after p53 re-expression. Moreover, activation of p53 induces formation of the repressive DREAM complex and results in enrichment of DREAM at mitotic gene promoters. Conversely, MMB is displaced at these promoters. Based on these findings the following model is proposed: In p53-negative cells, mitogenic stimuli foster the switch from DREAM to MMB. Thus, mitotic genes are overexpressed and may promote chromosomal instability and tumorigenesis. This study provides evidence that MMB contributes to the upregulation of G2/M phase-specific genes in p53-negative cells and suggests that inhibition of MMB (or its target genes) might be a strategy for treatment of lung cancer. 2017 urn:nbn:de:bvb:20-opus-154108 Graduate School of Life Sciences OPUS4-4541 Dissertation Ulrich, Tanja Function of Lin9 in vivo and MAP3K4-p38 signaling regulates p53 mediated cell cycle arrest after defective mitosis Eine genaue Kontrolle des Verlaufs durch die Mitose ist entscheidend für die Gewährleistung genomischer Stabilität und für die Vermeidung von Aneuploidy. Der DREAM Komplex ist ein wichtiger Regulator der Expression von mitotischen Genen. Die Depletion der DREAM-Untereinheit Lin9, führt zu einer verminderten Expression von G2/M Genen und beeinträchtigt die Proliferation. In konditionellen knockout Mauszellen (MEFs) verursacht das Ausschalten von Lin9 Defekte in Mitose und Zytokinese und löst vorzeitige Seneszenz aus, um eine weitere Zellproliferation zu verhindern. In dieser Arbeit konnte gezeigt werden, dass der seneszente Phänotyp in Lin9 knockout MEFs unabhängig von den beiden Tumorsuppressor-Signalwegen p53-p21 und p16-pRB induziert wird. Untersuchungen mit dem konditionellen Lin9 knockout Mausmodell verdeutlichten die wichtige Funktion von Lin9 in der Regulierung der mitotischen Genexpression und der Proliferation in vivo. Das Fehlen von Lin9 führte zu einer verringerten Proliferation in den Krypten des Dünndarms und verursachte eine Atrophie des Darmepithels und einen schnell eintretenden Tod der Tiere. Im zweiten Teil der Arbeit wurden Signalwege untersucht, die nach fehlerhafter Zytokinese zu einem p53 vermittelten G1-Arrest führen. Hierfür wurde ein chemischer Inhibitor der mitotischen Kinase Aurora B verwendet. Mit Hilfe eines Hochdurchsatz siRNA Screens wurde die MAP Kinase MAP3K4 als Aktivator des p53 Signalwegs identifiziert. Es konnte gezeigt werden, dass MAP3K4 die Stresskinase p38b aktiviert, um den p53 vermittelten Zellzyklusarrest in tetraploiden Zellen auszulösen. Dabei wurde p38b nach Hemmung von Aurora B für die transkriptionelle Aktivierung des p53 Zielgens p21 benötigt. Im Gegenteil dazu erfolgte die Phosphorylierung, Stabilisierung und die Rekrutierung von p53 an den p21 Promoter unabhängig von p38. Die teilweise Hemmung von Aurora B zeigte, dass fehlerhafte Segregation von Chromosomen auch den MAP3K4-p38-p53 Signalweg aktiviert und lässt darauf schließen, dass subtile Defekte in der Mitose ausreichen diesen Stress-Signalweg zu induzieren. Obwohl p38 für den G1 Zellzyklusarrest nach mitotischen Schäden erforderlich war, führte die gleichzeitige Inhibierung von p38 und Aurora B über einen längeren Zeitraum zu einer verringerten Proliferation, vermutlich aufgrund verstärkter Apoptose. Es ist anzunehmen, dass der MAP3K4-p38-p53 Signalweg generell nach Defekten in der Mitose oder Zytokinese aktiviert wird um Zellen in G1 zu arretieren und um chromosomale Instabilität zu vermeiden. 2012 urn:nbn:de:bvb:20-opus-73975 Theodor-Boveri-Institut für Biowissenschaften OPUS4-5410 Dissertation Schmitt, Kathrin Identification and Characterization of GAS2L3 as a Novel Mitotic Regulator in Human Cells Precise control of mitotic progression is vital for the maintenance of genomic integrity. Since the loss of genomic integrity is known to promote tumorigenesis, the identification of knew G2/M regulatory genes attracts great attention. LINC, a human multiprotein complex, is a transcriptional activator of a set of G2/M specific genes. By depleting LIN9 in MEFs, a core subunit of LINC, Gas2l3 was identified as a novel LINC target gene. The so far uncharacterized Gas2l3 gene encodes for a member of the family of growth arrest specific 2 (GAS2) proteins, which share a highly conserved putative actin binding CH and a putative microtubule binding GAS2 domain. In the present study GAS2L3 was identified as a LINC target gene also in human cells. Gene expression analysis revealed that GAS2L3 transcription, in contrast to all other GAS2 family members, is highly regulated during the cell cycle with highest expression in G2/M. The GAS2L3 protein showed a specific localization pattern during the M phase: In metaphase, GAS2L3 localized to the mitotic spindle, relocated to the spindle midzone microtubules in late anaphase and concentrated at the midbody in telophase where it persisted until the end of cytokinesis. Overexpression of a set of different GAS2L3 deletion mutants demonstrated that the localization to the mitotic microtubule network is dependent on the C-terminus, whereas the midbody localization is dependent on full length GAS2L3 protein. Additionally, exclusive overexpression of the CH domain induced the formation of actin stress fibers, suggesting that the CH domain is an actin binding domain. In contrast, the GAS2 domain was neither needed nor sufficient for microtubule binding, indicating that there must be an additional so far unknown microtubule binding domain in the C-terminus. Interestingly, immunoblot analysis also identified the C-terminus as the domain responsible for GAS2L3 protein instability, partially dependent on proteasomal degradation. Consistent with its specific localization pattern, GAS2L3 depletion by RNAi demonstrated its responsibility for proper mitosis and cytokinesis. GAS2L3 depletion in HeLa cells resulted in the accumulation of multinucleated cells, an indicator for chromosome mis-segregation during mitosis. Also the amount of cells in cytokinesis was enriched, indicating failures in completing the last step of cytokinesis, the abscission. Strikingly, treatment with microtubule poisons that lead to the activation of the spindle assembly checkpoint (SAC) indicated that the SAC was weakened in GAS2L3 depleted cells. Although the exact molecular mechanism is still unknown, fist experiments support the hypothesis that GAS2L3 might be a regulator of the SAC master kinase BUBR1. In conclusion, this study provides first evidence for GAS2L3 as a novel regulator of mitosis and cytokinesis and it might therefore be an important guardian against tumorigenesis. 2010 urn:nbn:de:bvb:20-opus-52704 Theodor-Boveri-Institut für Biowissenschaften OPUS4-3257 Dissertation Mannefeld, Mirijam Role of the human LIN complex in DNA damage induced regulation of gene expression In jeder menschlichen Zelle entstehen täglich ca. 10.000 - 150.000 endogene DNA Schäden. Eine Anhäufung dieser Läsionen kann zu genetischer Instabilität führen und dadurch zur Krebsentwicklung beitragen. Daher ist eine schnelle DNA Schadensantwort nötig, um schwerwiegende Folgen für die Zelle zu vermeiden. Da bekannt ist, dass der Multiproteinkomplex LINC (auch humaner dREAM-Komplex genannt) an der transkriptionellen Regulation mitotischer und G2-spezifischer Gene beteiligt ist, sollte in dieser Arbeit seine Beteiligung an der DNA Schadensantwort genauer untersucht werden. In der vorliegenden Arbeit wird gezeigt, dass in normal wachsenden Zellen B-MYB an den LINC-Kernkomplex bindet, welcher sich aus 5 Proteinen zusammensetzt: LIN-9, LIN-54, LIN-52, LIN-37 und RbAp48. Treten DNA Schäden auf, dissoziiert B-MYB vom LINC Kernkomplex wobei gleichzeitig die Bindung von p130 und E2F4 an LINC induziert wird. Zusätzlich konnte gezeigt werden, dass der Signalweg, der die LINC Umlagerung vermittelt, sowohl p53- als auch p21-abhängig ist. p53 negative Zellen können nach Schädigung der DNA weder einen G1 Block induzieren noch einen G2 Block langfristig aufrechterhalten. Eine Erklärung für diese Schwächung des G2 Arrests liefern Daten dieser Arbeit: Da in DNA geschädigten p53 -/- Zellen keine LINC Umlagerung beobachtet werden kann und zusätzlich B-MYB verstärkt an LINC und die Zielpromotoren bindet, kommt es zu einer erhöhten G2/M Genexpression. Dies resultiert häufig in einem verfrühten Wiedereintritt in den Zellzyklus („checkpoint adaptation"). Eine Daten-Analyse primärer Brustkrebstumore zeigte außerdem, dass erhöhte B-MYB Genexpressionslevel mit einer erhöhte Rückfallgefahr und einer schlechten Prognose korrelieren, was möglicherweise auf die Funktion von B-MYB während der „checkpoint adaptation" zurückzuführen ist. Schlussendlich lassen die Ergebnisse dieser Arbeit vermuten, dass die Hemmung der B-MYB Funktion in solchen Tumoren, die p53 Mutationen tragen, die Wahrscheinlichkeit eines Behandlungserfolges vergrößern und die Wahrscheinlichkeit eines Rückfalls senken könnte. 2009 urn:nbn:de:bvb:20-opus-39261 Theodor-Boveri-Institut für Biowissenschaften OPUS4-1837 Dissertation Hanisch, Anja Regulation of mitotic progression : Focus on Plk1 function and the novel Ska complex at kinetochores During mitosis the duplicated chromosomes have to be faithfully segregated into the nascent daughter cells in order to maintain genomic stability. This critical process is dependent on the rearrangement of the interphase microtubule (MT) network, resulting in the formation of a bipolar mitotic spindle. For proper chromosome segregation all chromosomes have to become connected to MTs emanating from opposite spindle poles. The MT attachment sites on the chromosomes are the kinetochores (KTs), which are also required to monitor the integrity of KT-MT interactions via the spindle assembly checkpoint (SAC). The first part of this work concerns the action of Polo-like kinase 1 (Plk1). Plk1 is one of the most prominent mitotic kinases and is involved in the regulation of multiple essential steps during mitosis consistent with its dynamic localisation to spindle poles, KTs and the central spindle. Despite a nice model of Plk1 targeting to different mitotic structures via its phosphopeptide binding Polo-box domain (PBD), the exact molecular details of Plk1 functioning, in particular at the KTs, remain obscure. By two different approaches we obtained cells with an unlocalised Plk1 kinase activity: first by generating stable HeLa S3 cell lines, which upon induction expressed the PBD and thus displaced endogenous Plk1 from its sites of action. Secondly, by rescuing cells RNAi-depleted of Plk1 with the catalytic Plk1 domain only. Centrosome maturation, bipolar spindle assembly and loss of cohesion between the chromatid arms proceeded normally in either cells, in contrast to Plk1-depleted cells, arguing that PBD-mediated targeting of Plk1 is less critical for the tested functions. Remarkably, however, both the PBD expressing as well as the Plk1-depleted cells rescued with the catalytic domain of Plk1 arrested in early mitosis in a SAC-dependent manner with uncongressed chromosomes. These data disclose a so far unrecognised role of Plk1 in proper chromosome congression and point at a particular requirement for PBD-mediated localised Plk1 activity at the KTs. In the second part of the thesis, we characterised a novel spindle and KT associated protein, termed Ska1, which was originally identified in a spindle inventory. Ska1 associated with KTs following MT attachment during prometaphase and formed a complex with at least another novel protein of identical localisation, called Ska2. Ska1 was required for Ska2 stability in vivo and depletion of either Ska1 or Ska2 resulted in the loss of both proteins from the KTs. The absence of Ska proteins did not disrupt overall KT structure but most strikingly induced cells to undergo a prolonged SAC-dependent delay in a metaphase-like state. The delay was characterised by weakened kinetochore-fibre stability, recruitment of Mad2 protein to a few KTs and the occasional loss of individual chromosomes from the metaphase plate. These data indicate that the Ska1/2 complex plays a critical role in the maintenance of a KT-MT attachments and/or SAC silencing. 2006 urn:nbn:de:bvb:20-opus-21467 Theodor-Boveri-Institut für Biowissenschaften OPUS4-99 Dissertation Grue, Pernille The physiological role of the two isoforms of DNA topoisomerase II in human cells Unique functions of DNA topoisomerase IIalpha and IIbeta have been suggested. A human cell line which carries a homozygeous mutation of the nuclear localization sequence of the topoisomerase IIalpha gene expresses the isoform outside the nucleus at the onset of mitosis. At mitosis topoisomerase IIbeta diffused away from the chromatin despite the nuclear lack of the IIalpha-form. Chromosome condensation and disjunction was performed with the aid of cytosolic topoisomerase IIalpha which bound to the mitotic chromatin with low affinity. Consequently an increased rate of nondisjunction is observed in these cells. It is concluded that high affinity chromatin binding of topoisomerase IIalpha is essential for chromosome condensation/disjunction and that topoisomerase IIbeta does not adopt these functions. A centrosomal protein was recognized by topoisomerase IIalpha. This topoisomerase IIalpha-like protein resembles a modified form of topoisomerase IIalpha with an apparent size of 205 kDa compared to 170 kDa. The expression of the protein is constant in all stages of the cell cycle and it appears in proliferating as well as in resting cells. If there is not sufficient topoisomerase IIalpha present at mitosis the centrosomal proteins might adopt the function and a mitotic catastrophe in the cells could therefore be prevented. 1999 urn:nbn:de:bvb:20-opus-1369 Medizinische Klinik und Poliklinik I